Skip to main content
TipRanks
Go Ultimate75% OFF

Venus Remedies Limited (VENUSREM) Stock Price & Analysis

1 Followers

VENUSREM Stock Chart & Stats

₹1,449.30-₹72.20(-4.75%)
At close: 3:30 PM GMT+5:30
₹1.25K₹1.5K₹1.75KAug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
INR 1,445.45 - INR 1,522.00
52-Week Range
INR 553.45 - INR 2,043.15
Previous Close
INR 1,521.50
Volume
N/A
Average Volume (3M)
3,882
Market Cap
INR 19.37B
Enterprise Value
INR 23.23B
Total Cash (Recent Filing)
INR 901.50M
Total Debt (Recent Filing)
INR 117.40M
Price to Earnings (P/E)
16.0
Beta
0.93
Next Earnings
Feb 14, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
0.69%

Bulls Say, Bears Say

Bulls Say

Revenue Growth

Positive revenue growth across the latest three reported years indicates renewed demand and commercial traction after the 2023 decline. Continued top-line expansion can support operating scale, strengthen market reach, and provide a durable base for future earnings growth.

Profitability Improvement

The sharp increase in net income and EBIT demonstrates substantial operating improvement in the latest period. If the stronger earnings level is maintained, it should improve internal funding capacity, support reinvestment in products, and enhance resilience across the business cycle.

Balance Sheet Strength

Very low leverage and steadily expanding equity give Venus Remedies meaningful financial flexibility. A conservative capital structure reduces dependence on external financing, helps absorb operating volatility, and leaves greater capacity to fund growth or manage unexpected pressure.

Bears Say

Margin Visibility

Material gross-margin swings make it harder to determine how much of the latest profit surge reflects durable operating improvement. Without clear evidence that margins remain elevated, future earnings could be less predictable and the current profitability level may be difficult to sustain.

Cash Flow Variability

Although recent cash generation improved, uneven conversion from earnings into operating cash flow indicates working-capital or investment-cycle variability. This can make internally generated funding less consistent and may complicate decisions on expansion, debt reduction, or shareholder returns.

Debt Volatility

Low leverage limits immediate balance-sheet risk, but changing absolute debt levels indicate that financing needs have not been completely stable. Further increases could raise interest obligations or reduce flexibility, particularly if profit margins or cash conversion weaken.

Venus Remedies Limited News

VENUSREM FAQ

What was Venus Remedies Limited’s price range in the past 12 months?
Venus Remedies Limited lowest stock price was ₹553.45 and its highest was ₹2043.15 in the past 12 months.
What is Venus Remedies Limited’s market cap?
Venus Remedies Limited’s market cap is ₹19.37B.
When is Venus Remedies Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Venus Remedies Limited’s earnings last quarter?
Venus Remedies Limited released its earnings results on Oct 26, 2026. The company reported ₹19.189 earnings per share for the quarter.
Is Venus Remedies Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Venus Remedies Limited pay dividends?
Venus Remedies Limited pays a dividend of ₹10 which represents an annual dividend yield of 0.69%. See more information on Venus Remedies Limited dividends here
What is Venus Remedies Limited’s EPS estimate?
Venus Remedies Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Venus Remedies Limited have?
Venus Remedies Limited has 13,366,988 shares outstanding.
What happened to Venus Remedies Limited’s price movement after its last earnings report?
Venus Remedies Limited reported an EPS of ₹19.189 in its last earnings report. Following the earnings report the stock price went up 4.222%.
Which hedge fund is a major shareholder of Venus Remedies Limited?
Currently, no hedge funds are holding shares in IN:VENUSREM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology